Patient P-01750

Synthetic patientNBL-101 · Day 108 · 35–44 · F · baseline S16Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Deteriorating

GI state

Deteriorating

Inflammatory state

Deteriorating

Nutritional resilience

Declining

Discontinuation risk

29%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S16

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Nutritional resilience-12
Inflammatory activity+8
Toxicity+7
GI instability+5
Treatment adherence-3

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

30.3/100

improving · -1.5 vs previous 14 d

Toxicity

Blood

22/100

improving · -4.1 vs previous 14 d

Sleep quality

Wearable

33.8/100

improving · +3.0 vs previous 14 d

Energy level

Daily log

5.6/10

improving · +0.6 vs previous 14 d

Stress level

Daily log

3.8/10

improving · -0.3 vs previous 14 d

Steps

Wearable

6,296

improving · +540 vs previous 14 d

Adherence

Companion

85.2 %

stable · +2.3 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 68 from the failing basin, 19 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.

Would not help

Keep histamine low
GI +3.4 next day on high-intake days · n 20

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Histamine load
+3.4detractor · 95%
Simple carbohydrates
+1.1no signal · 27%
Insoluble fibre
-0.7no signal · 19%
Alcohol
+0.4no signal · 15%
Spicy / capsaicin
+0.3no signal · 15%
Dietary fat load
+0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Autonomic recovery ↓45
- WearableResting HR 73 bpm
- WearableShort sleep window
Mucosal barrier integrity ↓40
- DNAFUT2 non-secretor lowers mucosal fucosylation
- WearableSleep 5.5 h, below personal baseline
Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion

DNA

Fictional pharmacogenomic panel

FUT2 rs601338 AA (non-secretor)
Reduced mucosal fucosylation
CYP2D6 Poor metabolizer
Higher exposure at standard dose
MTHFR C677T
Reduced folate turnover

Microbiome

Shannon diversity 4.1 · butyrate capacity 59/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 64 ms
Sleep: 6.1 h
Steps: 6,079
Resting HR: 69 bpm

Daily log: GI score 30, nutritional resilience 57, adherence 85.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01724	39%	S10	DT-01	improved	63
P-01571	38%	S13	SC-12	improved	57
P-01430	36%	S05	CR-01	improved	54
P-01555	35%	S06	GI-04	improved	56
P-01804	35%	S19	AD-05	improved	61
P-01455	34%	S01	GI-04	improved	61
P-01714	34%	S14	GI-04	improved	66
P-01752	34%	S20	DT-01	improved	50
P-01374	33%	S08	HY-01	improved	49
P-01593	33%	S10	HY-01	improved	56
P-01861	33%	S12	HY-01	improved	47
P-01321	32%	S12	GI-04	improved	53